Cannabidiol – Recent Advances
Copyright policy )Cannabidiol – Recent Advances
AbstractThe aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non‐psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly attractive therapeutic entity.
Antioxidants, Brain Ischemia, Neuroprotective Agents, Neoplasms, Receptor, Serotonin, 5-HT1A, Receptors, Opioid, Animals, Cannabidiol, Humans, Cannabinoid Receptor Antagonists
Antioxidants, Brain Ischemia, Neuroprotective Agents, Neoplasms, Receptor, Serotonin, 5-HT1A, Receptors, Opioid, Animals, Cannabidiol, Humans, Cannabinoid Receptor Antagonists
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).447 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!